Skip to main content

Table 1 Haemodynamic and prognostic data

From: Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

 

Time of presentation (/w dasatinib)

Time course under sildenafil (w/o dasatinib)

Month:

0

+1

+ 3

+ 5

+ 7

RVSP [mm Hg]

73

51

-

17

-

PAP mean [mm Hg]

52

-

-

-

40

PVR [dyn*s/cm -5 ]

1250

-

-

-

356

CO [l/min]

1.7

-

-

-

4.7

HR [/min]

105

-

-

-

85

proBNP [ng/l]

27055

3037

1334

2076

-

6MWD [m]

0

308

458

-

-

WHO/NYHA FC

IV

II

I/II

II

II

  1. RVSP: right ventricular systolic pressure; PAPmean: mean pulmonary artery pressure; PVR: pulmonary vascular resistance; CO: cardiac output; HR: heart rate; proBNP: brain natriuretic peptide propeptide; 6MWD: 6-minute walk distance; WHO/NYHA FC: World Health Organization/New York Heart Association functional class